Compare Johnson & Johnson (JNJ) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Open Text Corporation — how do they compare? Johnson & Johnson trades at $261.43 (market cap $618.09B), while Open Text Corporation trades at $23.7 (market cap $5.61B). The key difference: Johnson & Johnson is far larger — about 110.2× Open Text Corporation's market cap, and Open Text Corporation pays the higher dividend (4.82%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Open Text Corporation for 23 Days on average.
| JNJ | OTEX | |
|---|---|---|
Market Cap | $618.09B | $5.61B |
Volume | 6,050,983 | 1,197,475 |
Sector | Health | Technology |
52-Week High | $278.43 | $39.69 |
52-Week Low | $186.00 | $20.01 |
Typical Hold Time | 129 Days | 23 Days |
Enterprise Value | $646.37B | $10.63B |
Dividend Yield | 2.09% | 4.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
OpenText (OTEX) trades at $23.595, up 1.97% today, showing strong earnings momentum with three consecutive quarterly beats. The stock trades at discounted valuations (P/E 9.01, P/S 1.1) compared to sector peers. Recent corporate actions include a $1 billion senior secured notes offering and strategic AI partnership with Cohere, while technical indicators signal near-term bearish pressure with RSI at overbought levels.
The investment case balances attractive fundamentals against technical headwinds. Strong cloud growth (22.5% bookings growth in fiscal 2026) and improving margins support upside to the $28.30 consensus target, but high debt levels and bearish technical signals warrant caution. The stock offers value opportunity for patient investors despite near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
